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1. Introduction 
The synthesis of cyclic AMP in mouse epidermis 
can be stimulated via the /3-adrenergic route, for 
example by means of isoproterenol (IPR) [ 1,2]. This 
response has been found to be greatly diminished 
l-2 h after a single application of the tumor-pro- 
moting phorbol ester 12-O-tetradecanoylphorbol-13- 
acetate (TPA) and a correlation between this desen- 
sitization and tumor-promoting potency has been 
proposed [3,4]. Although it has been speculated [3] 
that the /3-adrenergic receptor itself is inactivated, 
the molecular mechanism of this effect remains 
obscure. There are indeed indications that after TPA- 
treatment no decrease of binding-sites for the /3- 
adrenergic antagonist [3H]dihydroalprenolol occurs 
[5] but that TPA ‘uncouples’ the @-adrenergic receptor 
from adenylate cyclase [6]. Here I present evidence 
that the development of TPA-induced catecholamine 
refractoriness in mouse epidermis in vivo may be 
dependent on RNA and protein synthesis and, there- 
fore, proceeds via a similar mechanism to catechol- 
amine-induced desensitization of the fl-adrenergic 
response [13]. 
2. Methods 
Female NMRI mice (7-g weeks) were kept and 
treated with TPA (local application in 0.1 ml acetone) 
or D,Lisoproterenol (intraperitoneal (i.p.) injection 
in 0.25 ml 0.9% NaCl solution) as in [3]. 
To determine the cyclic AMP level in dorsal 
epidermis, the animals were killed by cervical dislo- 
cation and after rapid dissection the skin was snap- 
frozen at -70°C. Under these conditions no increase 
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of cyclic AMP due to ischemia was observed. From 
the deep-frozen tissue the epidermis was scraped off 
with a pre-cooled scalpel and immediately homog- 
enized in 2.5 ml 5% trichloroacetic acid. After cen- 
trifugation the supernatant was extracted 5-times 
each with 2 ml water-saturated iethylether and lyo- 
philized. The dry residue was then dissolved in 2-5 
ml 0.2 M Tris-HCl buffer, containing 4 mM EDTA, 
and the cyclic AMP assay was carried out with 50 ~1 
aliquots using a commercially available assay kit based 
on a protein binding method (Amersham-Buchler, 
Brauuschweig). The DNA content of the epidermal 
homogenate was determined by carrying out the 
Burton reaction with the sediment of the first centrif- 
ugation as in [3]. Adenylate cyclase activity in epi- 
dermal homogenates was measured according to [7]. 
3. Results 
A single i.p. injection of isoproterenol caused a 
lo-20-fold increase of the level of cyclic AMP in 
dorsal mouse epidermis in <2.5 mm. (fig.1). At 7-10 
min the cyclic AMPcontent began to decline, reaching 
almost control levels after 20 min. The isoproterenol 
dose employed induced a maximal response and no 
further increase of cyclic AMP production was 
observed when the dose was raised to 1 mg/animal. 
As shown [ 1,2], the IPR-induced cyclic AMP syn- 
thesis is mediated by a /3-adrenergic receptor. 
When the animals had been pretreated by local 
application of the tumor-promoting phorbol ester 
TPA (20 nmol) the P-adrenergic stimulation was found 
to be greatly diminished (fig.lb; [3,4]). The catechol- 
amine refractoriness caused by TPA developed with a 
lag phase of -1 h (tig.lb). It could not be overcome 
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Fig.1. Effect of TPA on isoproterenol-induced cyclic AMP accumulation in dorsal mouse epidermis in vivo. D,L-isoproterenol 
(IPR, 0.25 mg/animal) was i.p. injected at zero time and the animals were killed at the times indicated. 3 h prior to IPR injection 
either 0.1 ml acetone (controls, (a)) or 20 nmol TPA in 0.1 ml acetone (b) were topically applied on to the shaved back skin. 
(a) The time course of cyclic AMP accumulation in acetone-treated animals after injection of IPR alone (-; n 1 6, SD) or when 
5 mg cycloheximide was i.p. injected 15 min prior to IPR injection (---; each point represents an experiment with 1 animal). 
(.b) The time course of cyclic AMP accumulation in TPA-treated animals. (e-e) Injection of IPR alone (n > 4, SD). (o . o) 
Two i.p. injections of cycloheximide were given 1 h (5 mg/animal) and 2 h (2.5 mg/anImal) after TPA application. (A--A) 2.5 mg 
Azacyctidine was i.p. injected 20 min prior to TPA application. Each o or A represents an experiment with 1 animal. 
Insert: The level of cyclic AMP (pmol/rg DNA) in dorsal mouse epidermis as measured 7 min after an injection of 0.25 mg IPR 
given at different time intervals after local application of 20 nmol TPA at zero time (n = 6, SD). 
Table 1 
Activity of adenylate cyclase in epidermal homogenates from control and 
TPA-treated mice 
Assay 
conditions 
Formation of 5’-AMP (cpm . min-’ . mg protein-‘) 
Control TPA-treated 
I II III 1 II III 
Normal 361 310 440 393 330 352 
50 mM NaF 1320 1470 1560 1432 1660 1810 
The animals were topically treated with either 0.1 ml acetone (controls) or a solu- 
tion of 20 nmol TPA in 0.1 ml acetone 3 h prior to killing as in fig.1. Enzyme 
activity was measured according to [7]. 
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by 1-methyl-34sobutylxanthine (MIX), a powerful 
inhibitor of epidermal cyclic AMP phosphodiesterase 
(Ki - 25 PM). When fig.2 is compared with fig.1 it can 
be seen that MIX-trea’;ment did not alter the relation- 
ship between cyclic AMP accumulation in control and 
TPA-treated animals. Therefore, the refractoriness 
cannot be due to enhanced cyclic AMP-phosphodi- 
esterase activity. Desensitization could be entirely 
prevented when the animals had been treated with 
cycloheximide (fig.1) in a dose which strongly sup- 
pressed epidermal protein biosynthesis in vivo [ 121. 
Best results were obtained when the inhibitor was 
applied twice 1 h and 2 h after TPA treatment. But 
also a single dose given either simultaneously or 1 h 
after TPA application could largely overcome the 
desensitization of the fi-adrenergic response whereas 
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Fig.2. Cyclic AMP accumulation in dorsal mouse epidermis in 
vivo after combined injection of 1-methyl-3-isobutyl-xanthine 
(MIX) and D,L-isoproterenol (IPR): effect of pretreatment 
with acetone (--) or TPA (---). The animals which had 
been pretreated with either acetone or 20 nmol TPA 3 h 
before (see fgl) received an i.p. injection of IPR (0.25 mg/ 
mouse) at zero time and were killed at the times indicated. 
40 min prior to killing 1.5 mg MIX/O .1 ml acetone was locally 
applied on to the shaved back skin and 20 min prior to 
sacrifice an i.p. injection of 1 mg MIX/O.3 ml isotonic NaCl, 
solution was made. Each point represents an experiment with 
1 animal. 
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Fig.3. Effect of cycloheximide on IPR-induced cyclic AMP 
accumulation in dorsal mouse epidermis in vivo after pretreat- 
ment with TPA. TPA (20 nmol) was topically applied 3 h 
prior to IPR injection. 
(a) The relationship between cyclic AMP accumulation (as 
measured 7 min after injection of 0.25 mg IPR) and scheme 
of cycloheximide injection (5 mg/animal i.p.; -, application 
prior to TPA, +, application after TPA). 
(b) The accumulation of cyclic AMP (as measured 7 min 
after i.p. injection of 0.25 mg IPR) in animals which had 
received either 2 (A, 5 mg 1 h after TPA, 2.5 mg 2 h after 
TPA) or 3 (B, 5 mg each 5 min before and 1 h after TPA, 
2.5 mg 2 h after TPA) injections of cycloheximide. Each 
point represents an experiment with one animal. The hatched 
zones represent he average standard deviations of the cyclic 
AMP level as measured 7 mm after IPR-injection in either 
acetone-treated (upper zone, n = 12) or TPA-treated mice 
(lower zone, n = 12) which had received intraperitoneal 
injections of 0.3 ml 0.9% NaCl solution instead of cyclo- 
heximide. 
injections given either 30 min before or 2 h after 
TPA were less effective (fig.3). TPA-induced cate- 
cholamine refractoriness could be also prevented by 
azacytidine (fig. 1 b) in a dose which is known to 
inhibit epidermal RNA synthesis in vivo [ 111. 
As shown in table 1 the activity of adenylate 
cyclase as measured in epidermal homogenates was 
not altered after TPA treatment. 
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4. Discussion References 
These results indicate that the TPA-induced cate- 
cholamine refractoriness in mouse epidermis in vivo is 
due to a complex process which can be inhibited by 
cycloheximide or azacytidine and, therefore, proba- 
bly involves the de novo synthesis of RNA and pro- 
tein. 
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